Mark Shephard

2.1k total citations
100 papers, 1.4k citations indexed

About

Mark Shephard is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Epidemiology. According to data from OpenAlex, Mark Shephard has authored 100 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Endocrinology, Diabetes and Metabolism, 30 papers in Physiology and 23 papers in Epidemiology. Recurrent topics in Mark Shephard's work include Diabetes, Cardiovascular Risks, and Lipoproteins (23 papers), Clinical Laboratory Practices and Quality Control (22 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (12 papers). Mark Shephard is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (23 papers), Clinical Laboratory Practices and Quality Control (22 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (12 papers). Mark Shephard collaborates with scholars based in Australia, United States and Timor-Leste. Mark Shephard's co-authors include Beryl Mazzachi, Janice Gill, M.J. Whiting, Callum G. Fraser, M J Peake, Rebecca Guy, Malcolm J. Whiting, Steven G. Badman, James Ward and George A. Tallis and has published in prestigious journals such as PLoS ONE, Diabetes Care and Kidney International.

In The Last Decade

Mark Shephard

94 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Shephard Australia 25 366 354 278 226 206 100 1.4k
Digsu N. Koye Australia 22 615 1.7× 134 0.4× 243 0.9× 137 0.6× 454 2.2× 46 1.9k
Ellen Funkhouser United States 29 74 0.2× 153 0.4× 408 1.5× 334 1.5× 373 1.8× 94 2.6k
Judith A. O’Brien Canada 22 394 1.1× 69 0.2× 147 0.5× 127 0.6× 518 2.5× 43 1.9k
O. Dale Williams United States 17 248 0.7× 372 1.1× 274 1.0× 352 1.6× 373 1.8× 30 2.0k
Fiona Turnbull Australia 22 1.3k 3.5× 186 0.5× 218 0.8× 315 1.4× 493 2.4× 40 3.7k
Aiman El‐Saed Saudi Arabia 26 249 0.7× 184 0.5× 110 0.4× 205 0.9× 810 3.9× 128 2.4k
Jean‐Blaise Wasserfallen Switzerland 22 43 0.1× 184 0.5× 235 0.8× 99 0.4× 223 1.1× 74 1.5k
Deven Juneja India 19 101 0.3× 61 0.2× 139 0.5× 209 0.9× 509 2.5× 87 1.8k
Arvind Gupta India 20 633 1.7× 157 0.4× 61 0.2× 232 1.0× 562 2.7× 60 1.7k
Stephen R. Benoit United States 22 780 2.1× 119 0.3× 290 1.0× 209 0.9× 731 3.5× 61 2.3k

Countries citing papers authored by Mark Shephard

Since Specialization
Citations

This map shows the geographic impact of Mark Shephard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Shephard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Shephard more than expected).

Fields of papers citing papers by Mark Shephard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Shephard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Shephard. The network helps show where Mark Shephard may publish in the future.

Co-authorship network of co-authors of Mark Shephard

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Shephard. A scholar is included among the top collaborators of Mark Shephard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Shephard. Mark Shephard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hengel, Belinda, Rebecca Guy, Lorraine Anderson, et al.. (2025). Decentralised COVID‐19 molecular point‐of‐care testing: lessons from implementing a primary care‐based network in remote Australian communities. The Medical Journal of Australia. 222(4). 172–178. 1 indexed citations
2.
Badman, Steven G., Annie Tangey, Kirsty Smith, et al.. (2023). Flexible and Innovative Connectivity Solution to Support National Decentralized Infectious Diseases Point-of-Care Testing Programs in Primary Health Services: Descriptive Evaluation Study. Journal of Medical Internet Research. 25. e46701–e46701. 7 indexed citations
3.
4.
Guy, Rebecca, James Ward, Louise Causer, et al.. (2018). Molecular point-of-care testing for chlamydia and gonorrhoea in Indigenous Australians attending remote primary health services (TTANGO): a cluster-randomised, controlled, crossover trial. The Lancet Infectious Diseases. 18(10). 1117–1126. 28 indexed citations
5.
Causer, Louise, Rebecca Guy, Sepehr N. Tabrizi, et al.. (2018). Molecular test for chlamydia and gonorrhoea used at point of care in remote primary healthcare settings: a diagnostic test evaluation. Sexually Transmitted Infections. 94(5). 340–345. 32 indexed citations
6.
Shephard, Mark, et al.. (2017). Clinical Application of Point-of-Care Testing in theRemote Primary Health Care Setting. Quality in primary care. 25(3). 3 indexed citations
7.
Shephard, Mark, et al.. (2017). Point-of-care testing improves diabetes management in a primary care clinic in South Africa. Primary care diabetes. 11(3). 248–253. 29 indexed citations
8.
Shephard, Mark, et al.. (2017). Results from 15 years of quality surveillance for a National Indigenous Point-of-Care Testing Program for diabetes. Clinical Biochemistry. 50(18). 1159–1163. 8 indexed citations
9.
Natoli, Lisa, Rebecca Guy, Mark Shephard, et al.. (2015). Public health implications of molecular point-of-care testing for chlamydia and gonorrhoea in remote primary care services in Australia: a qualitative study. BMJ Open. 5(4). e006922–e006922. 19 indexed citations
10.
Shephard, Mark, et al.. (2015). Review of the cultural safety of a national Indigenous point-of-care testing program for diabetes management. Australian Journal of Primary Health. 22(4). 368–368. 10 indexed citations
11.
Natoli, Lisa, Lisa Maher, Mark Shephard, et al.. (2014). Point-of-Care Testing for Chlamydia and Gonorrhoea: Implications for Clinical Practice. PLoS ONE. 9(6). e100518–e100518. 26 indexed citations
12.
Khalil, Hanan, Heather Halls, Helen Phyllis Chambers, Judi Walker, & Mark Shephard. (2013). Managing chronic diseases in rural aged care facilities using point-of-care testing systems. Rural and Remote Health. 13(3). 2597–2597. 5 indexed citations
13.
Shephard, Mark, et al.. (2012). Guidelines and recommendations for the quality-assured conduct of point-of-care testing for infectious diseases and drugs of abuse in Australia. 33(4). 143–154. 2 indexed citations
14.
Shephard, Mark, et al.. (2012). Design, implementation and initial assessment of the Northern Territory Point‐of‐Care Testing Program. Australian Journal of Rural Health. 20(1). 16–21. 18 indexed citations
15.
Tirimacco, Rosy, et al.. (2011). Development of an accreditation program for Point of Care Testing (PoCT) in general practice. Australian Health Review. 35(2). 230–234. 8 indexed citations
16.
Shephard, Mark, et al.. (2009). Evaluation of a training program for device operators in the Australian government's point of care testing In general practice trial. Rural and Remote Health. 9(3). 5 indexed citations
17.
18.
19.
Shephard, Mark & George A. Tallis. (2002). Assessment of the point-of-care Cholestech Lipid Analyser for lipid screening in Aboriginal communities. Flinders Academic Commons (Flinders University). 23(1). 4–10. 4 indexed citations
20.
Shephard, Mark. (1990). Guidelines for the establishment of a correspondence course in basic clinical chemistry. 2(2). 66–71. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Digsu N. Koye Breakdown of academic impact, for papers by Ellen Funkhouser Breakdown of academic impact, for papers by Judith A. O’Brien Breakdown of academic impact, for papers by O. Dale Williams Breakdown of academic impact, for papers by Fiona Turnbull Breakdown of academic impact, for papers by Aiman El‐Saed Breakdown of academic impact, for papers by Jean‐Blaise Wasserfallen Breakdown of academic impact, for papers by Deven Juneja Breakdown of academic impact, for papers by Arvind Gupta Breakdown of academic impact, for papers by Stephen R. Benoit
Rankless by CCL
2026